tiprankstipranks
Advertisement
Advertisement

CERO Stock Latest News

CERo Therapeutics Secures Convertible Note Financing Facility
Company AnnouncementsCERo Therapeutics Secures Convertible Note Financing Facility
15d ago
8K
CERO
CERo Therapeutics Delays 2025 Annual Report Filing
PremiumCompany Announcements
CERo Therapeutics Delays 2025 Annual Report Filing
27d ago
CERO
Cero Therapeutics issues letter to shareholders
PremiumThe Fly
Cero Therapeutics issues letter to shareholders
2M ago
CERO
CERo Therapeutics Enters Convertible Note Financing Agreement
PremiumCompany Announcements
CERo Therapeutics Enters Convertible Note Financing Agreement
2M ago
8K
CERO
Cero Therapeutics appoints Eric Francois to board of directors
PremiumThe Fly
Cero Therapeutics appoints Eric Francois to board of directors
2M ago
CERO
SCYX
CERo Therapeutics Announces Convertible Note Financing and New Director
PremiumCompany AnnouncementsCERo Therapeutics Announces Convertible Note Financing and New Director
2M ago
8K
CERO
Cero Therapeutics to present data from Phase 2 trial of CER-1236
Premium
The Fly
Cero Therapeutics to present data from Phase 2 trial of CER-1236
3M ago
CERO
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
Premium
Company Announcements
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
3M ago
8K
CERO
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
PremiumCompany Announcements
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
4M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
PremiumThe Fly
Cero Therapeutics provides update on Phase 1 trial of CER-1236
4M ago
CERO
CERo Therapeutics shareholders approve key capital structure changes
PremiumCompany Announcements
CERo Therapeutics shareholders approve key capital structure changes
4M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
PremiumThe Fly
Cero Therapeutics provides update on Phase 1 trial of CER-1236
4M ago
CERO
CERo Therapeutics Enters New $14.6M Stock Agreement
PremiumCompany AnnouncementsCERo Therapeutics Enters New $14.6M Stock Agreement
5M ago
8K
CERO
Cero Therapeutics announces trading on OTCQB Market
Premium
The Fly
Cero Therapeutics announces trading on OTCQB Market
5M ago
CERO
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
5M ago
CERO
CERo Therapeutics Delays Quarterly Report Filing
PremiumCompany Announcements
CERo Therapeutics Delays Quarterly Report Filing
5M ago
CERO
Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
PremiumThe Fly
Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
6M ago
CERO
Cero Therapeutics to present data on CER-1236 at SITC conference
PremiumThe Fly
Cero Therapeutics to present data on CER-1236 at SITC conference
6M ago
CERO
Cero Therapeutics announces listing on OTC Markets
PremiumThe Fly
Cero Therapeutics announces listing on OTC Markets
6M ago
CERO
Cero Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe FlyCero Therapeutics downgraded to Hold from Buy at Maxim
6M ago
CERO
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
6M ago
FI
MA
Why Is CERo Therapeutics Stock Down 80% Today?
Premium
Market News
Why Is CERo Therapeutics Stock Down 80% Today?
6M ago
CERO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >